Clinical Trial Update: Capecitabine + Bevacizumab in Patients With Recurrent Glioblastoma [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update on combining capecitabine with bevacizumab in patients with recurrent glioblastoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• Avastin (bevacizumab)
• Xeloda (capecitabine)

Snippet

Sponsor: Case Comprehensive Cancer Center | Conditions: Glioblastoma | Phase 1 | Status: COMPLETED